Metraipolis › archive › dc_db60ea1f6f41
Personalized MASLD and liver fibrosis risk assessment for adults: glycemic status determines optimal choice of non-invasive indices — Europe PMC PMID:41430716
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41430716
- DOI
- 10.1186/s13098-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T11:21:28.851Z
- SHA-256 of the archived text
a1c2780c53b8add862ebfdc6c73d71c8edbe43ff71e47ddc7ad804da76061e28- Stable URL of this page
https://metraipolis.com/documento/dc_db60ea1f6f41
How to cite
Personalized MASLD and liver fibrosis risk assessment for adults: glycemic status determines optimal choice of non-invasive indices — Europe PMC PMID:41430716 — Europe PMC (en), https://europepmc.org/article/MED/41430716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db60ea1f6f41 (Metraipolis archive dc_db60ea1f6f41, sha256 a1c2780c53b8add862ebfdc6c73d71c8edbe43ff71e47ddc7ad804da76061e28)
BibTeX
@misc{dcdb60ea1f6f41,
title = {Personalized MASLD and liver fibrosis risk assessment for adults: glycemic status determines optimal choice of non-invasive indices — Europe PMC PMID:41430716},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41430716},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db60ea1f6f41; sha256 a1c2780c53b8add862ebfdc6c73d71c8edbe43ff71e47ddc7ad804da76061e28},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41430716. Agents can read the archived copy with the MCP tool read_document.